No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs148746300 |
chr2:95734214-95734215 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs372133468 |
chr2:95734215-95734216 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs59021305 |
chr2:95734217-95734218 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs3105103 |
chr2:95734218-95734219 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
5 |
rs555269195 |
chr2:95734227-95734228 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs575172103 |
chr2:95734296-95734297 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs77332441 |
chr2:95734330-95734331 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs559297346 |
chr2:95734350-95734351 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs187949654 |
chr2:95734400-95734401 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs528114855 |
chr2:95734422-95734423 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs545046457 |
chr2:95734451-95734452 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs13005775 |
chr2:95734474-95734475 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
13 |
rs191993852 |
chr2:95734479-95734480 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs13005783 |
chr2:95734485-95734486 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs550374589 |
chr2:95734574-95734575 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs567155015 |
chr2:95734609-95734610 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs2320619 |
chr2:95734623-95734624 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
18 |
rs546620416 |
chr2:95734755-95734756 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs566820427 |
chr2:95734787-95734788 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs184544853 |
chr2:95734796-95734797 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs141792744 |
chr2:95734802-95734803 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs397976588 |
chr2:95734812-95734813 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs151306160 |
chr2:95734967-95734968 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs187657916 |
chr2:95734997-95734998 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs554528881 |
chr2:95734998-95734999 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs555179455 |
chr2:95735011-95735012 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs573191699 |
chr2:95735012-95735013 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs540403750 |
chr2:95735032-95735033 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs34986561 |
chr2:95735073-95735074 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs192658100 |
chr2:95735092-95735093 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs2320620 |
chr2:95735140-95735141 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs569669783 |
chr2:95735163-95735164 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs185000815 |
chr2:95735168-95735169 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs536622603 |
chr2:95735172-95735173 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs572749854 |
chr2:95735210-95735211 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs140647016 |
chr2:95735231-95735232 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs564956927 |
chr2:95735233-95735234 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs530503364 |
chr2:95735266-95735267 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs374300811 |
chr2:95735286-95735287 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs560742652 |
chr2:95735308-95735309 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs529850944 |
chr2:95735312-95735313 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs546828246 |
chr2:95735318-95735319 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs566677461 |
chr2:95735435-95735436 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs189065021 |
chr2:95735457-95735458 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs552273673 |
chr2:95735458-95735459 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs569302833 |
chr2:95735478-95735479 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs375729607 |
chr2:95735483-95735484 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs377251300 |
chr2:95735504-95735505 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs180974993 |
chr2:95735551-95735552 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs532385399 |
chr2:95735574-95735575 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|